Efficacy and Safety of Abrocitinib Versus Dupilumab in Patients Who Self-Identified as Having Skin of Color: A Post Hoc Analysis of JADE COMPARE. J of Skin. 2026;10(2):s733. doi:10.25251/8r6ert44